Skip to main content
. 2015 Dec 18;94(50):e2262. doi: 10.1097/MD.0000000000002262

FIGURE 2.

FIGURE 2

Comparison of the cumulative event-free survival rates among groups. Group A: asprin + clopidogel + atorvastatin + lansoprazole; Group B: asprin + clopidogel + atorvastatin; Group C: asprin + clopidogel + lansoprazole + rosuvastatin; Group D: asprin + clopidogel + rosuvastatin.